BioCardia

(NASDAQ) BCDA

Current Price$0.87

Market Cap$10.01M

Since IPO (2016)-100%

5 Year-99%

1 Year-60%

1 Month-18%

BioCardia Financials at a Glance

Market Cap

$10.01M

Revenue (TTM)

$0.00

Net Income (TTM)

-$7.78M

EPS (TTM)

-$1.03

P/E Ratio

-0.85

Dividend

$0.00

Beta (Volatility)

0.64 (Low)

Dividend

$0.00

Beta (Volatility)

0.64 (Low)

Price

$0.87

Volume

8,547

Open

$0.82

Price

$0.87

Volume

8,547

Open

$0.82

Previous Close

$0.87

Daily Range

$0.82 - $0.89

52-Week Range

$0.78 - $2.45

Estimated Earnings Date

Aug 10, 2026

Dividend

$0.00

Beta (Volatility)

0.64 (Low)

Price

$0.87

Volume

8,547

Open

$0.82

Previous Close

$0.87

Daily Range

$0.82 - $0.89

52-Week Range

$0.78 - $2.45

Estimated Earnings Date

Aug 10, 2026

BCDA News

BioCardia Narrows Loss in Fiscal Q2

Motley Fool Markets TeamAug 11, 2025

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About BioCardia

Industry

Biotechnology

Sector

Health Care

Employees

CEO

Peter Alan Altman, PhD

Website

www.biocardia.com

Headquarters

Sunnyvale, CA 94085, US

BCDA Financials

Key Financial Metrics (TTM)

Gross Margin

Operating Margin

Net Income Margin

Return on Equity

-950%

Return on Capital

Return on Assets

-5%

Earnings Yield

-1.18%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$10.01M

Shares Outstanding

11.37M

Volume

8.55K

Avg. Volume

2.70M

Financials (TTM)

Gross Profit

-$505.00K

Operating Income

-$8.28M

EBITDA

-$7.72M

Operating Cash Flow

-$7.44M

Capital Expenditure

-$7.00K

Free Cash Flow

-$7.44M

Cash & ST Invst.

$2.50M

Total Debt

$528.00K

BioCardia Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q1 2026YOY CHG

Revenue

$0.00

N/A

Gross Profit

-$124.00K

+91.9%

Gross Margin

0.00%

N/A

Market Cap

$10.01M

N/A

Market Cap/Employee

$588.81K

N/A

Employees

N/A

Net Income

-$2.26M

+16.7%

EBITDA

-$2.14M

+20.9%

Quarterly Fundamentals

Name

Q1 2026YOY CHG

Total Cash

$951.00K

+0.2%

Total Debt

$412.00K

-51.5%

Accounts Receivable

$20.00K

N/A

Inventory

$0.00

N/A

Long Term Debt

$0.00

-100.0%

Short Term Debt

$412.00K

+3.5%

Return on Assets

-4.54%

N/A

Return on Invested Capital

7.33%

N/A

Free Cash Flow

-$1.66M

-2.7%

Operating Cash Flow

-$1.66M

-2.5%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

APVOAptevo Therapeutics Inc.

APVOAptevo Therapeutics Inc.$4.78-1.65%

KPRXKiora Pharmaceuticals, Inc.

KPRXKiora Pharmaceuticals, Inc.$2.55-1.92%

PHIOPhio Pharmaceuticals Corp.

PHIOPhio Pharmaceuticals Corp.$1.07-0.93%

INABIN8bio, Inc.

INABIN8bio, Inc.$1.43-0.69%

CELZCreative Medical Technology Holdings, Inc.

CELZCreative Medical Technology Holdings, Inc.$2.17+1.88%

APREAprea Therapeutics, Inc.

APREAprea Therapeutics, Inc.$0.69-10.31%

ALZNAlzamend Neuro, Inc.

ALZNAlzamend Neuro, Inc.$1.21+5.68%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

SPCXSpace Exploration Technologies

SPCXSpace Exploration Technologies$160.95+0.19%

AALAmerican Airlines Group

AALAmerican Airlines Group$14.98+0.02%

NOKNokia

NOKNokia$14.80+0.05%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$13.59+0.04%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$77.52+0.02%

SMCISuper Micro Computer

SMCISuper Micro Computer$30.46-0.05%

SQQQProShares Trust - ProShares UltraPro Short Qqq

SQQQProShares Trust - ProShares UltraPro Short Qqq$40.04-0.02%

Questions About BCDA

What is the current price of BioCardia?

BioCardia is trading at $0.87 per share.

What is the 52-week range for BioCardia?

Over the past 52 weeks, BioCardia has traded between $0.78 and $2.45.

How much debt does BioCardia have?

As of the most recent reporting period, BioCardia reported total debt of $412.00K.

How much cash does BioCardia have on hand?

BioCardia reported $951.00K in cash and cash equivalents in its most recent financial results.

What is BioCardia’s dividend yield?

BioCardia does not currently have a dividend yield.

BioCardia

BioCardia Financials at a Glance

BCDA News

BioCardia Narrows Loss in Fiscal Q2

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About BioCardia

BCDA Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

BioCardia Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About BCDA

What is the current price of BioCardia?

What is the 52-week range for BioCardia?

How much debt does BioCardia have?

How much cash does BioCardia have on hand?

What is BioCardia’s dividend yield?

Premium Investing Services